2023-508656-19-00CompletedPhase 1
Bioequivalence of Cladribine 10 mg from two different products
Source: EU CTIS (euclinicaltrials.eu) · Last updated 6 Feb 2024
- Status (registry)
- Completed
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 76 (actual)
- First submitted
- 24 Nov 2023
- Start date
- 1 Mar 2024
- Lead sponsor
- CCDRD Cooperative Clinical Drug Research and Development AG
- EU CT number
- 2023-508656-19-00
What you commit to
- Study type: Interventional · Phase 1
- Participants enrolled: 76
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (2)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Bed space for short term stay at Diagnostic & Consultative Centre 'Ascendent' Ltd. | Sofia | Bulgaria | Completed |
| Clinic of Clinical Pharmacology and Therapeutics at UMHAT 'Tsaritsa Ioanna-ISUL' EAD | Sofia | Bulgaria | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.